NutriBand Terminates Subsidiary Sale Due to Buyer's Payment Default
NTRB is trading near its 52-week low of $4.06 (1.2% above the low) on light trading volume (0.1× avg).
Summary
NutriBand Inc. announced the immediate termination of its agreement to sell subsidiary Pocono Pharmaceuticals, Inc., citing the buyer's failure to pay required late fees.
Key Events · M&A and Partnerships · NTRB
-
Subsidiary Sale Terminated
NutriBand's Board of Directors approved the immediate termination of the agreement to sell Pocono Pharmaceuticals, Inc. to Earth Vision Bio Inc.
-
Buyer Defaulted on Payments
The termination was due to Earth Vision Bio Inc.'s failure to pay applicable late fees under the purchase agreement, with no payments received since January 21, 2026.
-
Strategic Implications
This event adds to recent concerns, including a substantial net loss and an increase in authorized preferred stock, and occurs while the stock trades near its 52-week low.
Analysis · NTRB · Industrial Applications And Services
The termination of the sale of Pocono Pharmaceuticals, Inc. to Earth Vision Bio Inc. is a significant setback for NutriBand. The buyer's failure to make required payments indicates potential financial or operational issues with the acquiring party, or challenges in the deal itself. This news comes as NutriBand is trading near its 52-week low and follows recent disclosures of a substantial net loss and an increase in authorized preferred stock, suggesting ongoing financial pressures. The company will now need to reassess its strategy for Pocono Pharmaceuticals and potentially seek new buyers or integrate it back into its operations, which could impact its capital structure and future financial performance.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1594 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NTRB was trading at $4.11 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $50M. The 52-week trading range was $4.06 to $11.68. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.